Windtree Ebt Per Ebit from 2010 to 2025
| WINT Stock | USD 0.08 0.01 14.29% |
Ebt Per Ebit | First Reported 2010-12-31 | Previous Quarter 0.07166553 | Current Value 0.0681 | Quarterly Volatility 0.36149084 |
Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.8 K, Interest Expense of 223.2 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 665, Dividend Yield of 0.58 or PTB Ratio of 0.0873. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.
Windtree | Ebt Per Ebit | Build AI portfolio with Windtree Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.